Brain Tumor Biotech Summit held in Manhattan on 29 May, 2015

Voices Against Brain CancerMay 30 2015

Voices Against Brain Cancer, a national non-profit organization committed to finding a cure for brain cancer and brain tumors, and the Feinstein Institute for Medical Research in Long Island, will be hosting a Brain Tumor Biotech Summit on Friday, May 29^th, 2015 at Lenox Hill Hospital's Einhorn Auditorium in Manhattan. The one-day event is designed to bring together top researchers, doctors, investors, biotech companies, and more, who are exceptionally involved in neuroscience and oncology, to share information on emerging therapies for brain tumors.

With the support from industry leaders from around the world, during the summit, leading brain tumor researchers and doctors will present their latest advancements in neuroscience, all which are relevant to the treatment of brain cancer.

Key Note Speakers include:

• Robert B. Darnell MD, PhD, The Rockefeller University
• Michael Lim, MD, Johns Hopkins University
• Donald M. O'Rourke, MD, University of Pennsylvania
• Michael A. Vogelbaum, MD, PhD, FAANS, FACS, Case Western Reserve University

Special Guests include:

• Michael J. Dowling, President and CEO of North Shore-LIJ Health System
• Anthony Scaramucci, Founder and Managing Partner at SkyBridge Capital
• Kevin J. Tracey, MD, President and CEO of the Feinstein Institute for Medical Research

Each will provide insight into the future of biotech companies and the use of their drugs. Data on CAR-T Immune Biotechnology will also be presented by Donald O'Rourke, as this innovative technology has seen great success in certain types of Leukemia, and has achieved long term remissions in patients who have exhausted other treatments in their battle with cancer.

Seminars throughout the day include Immunomodulatory Therapies for Glioblastoma, New Delivery Modalities and Novel Applications and Treatment for Malignant Glioma.

"With thousands of families afflicted by this devastating disease each year, our organization continues the push for awareness and research for a cure," said Mario Lichtenstein, Founder of Voices Against Brain Cancer. "By bringing together such remarkable innovators from the medical field through the Biotech Summit, we are able to learn more about the advancements and research being made each day, to ultimately find a cure for brain tumors and brain cancer."

Voices Against Brain Cancer, leaders in the brain cancer community, was founded in loving memory of Gary Lichtenstein, who lost his valiant battle with brain cancer on October 1, 2003. Since then, the organization has garnered support from other patients, survivors, their families, caregivers, prestigious doctors and celebrities, all united in their drive towards finding a cure for this devastating disease.